Pharma Mar SA
MAD:PHM

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
MAD:PHM
Watchlist
Price: 79.85 EUR -1.11% Market Closed
Market Cap: 1.4B EUR
Have any thoughts about
Pharma Mar SA?
Write Note

Pharma Mar SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharma Mar SA
Cost of Revenue Peer Comparison

Comparables:
GRF
ORY
BST

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Mar SA
MAD:PHM
Cost of Revenue
-€10.5m
CAGR 3-Years
16%
CAGR 5-Years
-15%
CAGR 10-Years
11%
Grifols SA
MAD:GRF
Cost of Revenue
-€4.1B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Oryzon Genomics SA
MAD:ORY
Cost of Revenue
-€1.1m
CAGR 3-Years
-19%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Biotechnology Assets SA
MAD:BST
Cost of Revenue
-€1.1m
CAGR 3-Years
-40%
CAGR 5-Years
45%
CAGR 10-Years
N/A

See Also

What is Pharma Mar SA's Cost of Revenue?
Cost of Revenue
-10.5m EUR

Based on the financial report for Jun 30, 2024, Pharma Mar SA's Cost of Revenue amounts to -10.5m EUR.

What is Pharma Mar SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
11%

Over the last year, the Cost of Revenue growth was 19%. The average annual Cost of Revenue growth rates for Pharma Mar SA have been 16% over the past three years , -15% over the past five years , and 11% over the past ten years .

Back to Top